DB05849ExperimentalSmall molecule
NCX 950, beta2-adrenoceptor agonists is widely used in the treatment of pulmonary diseases.
- Mechanism
- Curator reviewed
NCX-950 elicits potent relaxant and anti-inflammatory activities compared with salbutamol, and these effects may be mainly due to the activation of the beta2-adrenoceptor rather than the cGMP pathway.
- Primary indication
- Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD).Curator reviewed
- Code names
- NCX 950
Resolves to
Targets
What you can answer from here — as of April 02, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with NCX 950, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account